Analytical Data
-
Gene name
CCL4L1
- Application
-
Alternative Names
LAG1; CCL4L; LAG1; SCYA4L; Monocyte adherence-induced protein 5-alpha; Small-inducible cytokine A4-like; Lymphocyte activation gene 1; Macrophage inflammatory 1-beta
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8NHW4
-
Expression Region
Ala24~Asn92
-
Molecular Weight
38kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCL4L1, a chemokine belonging to the CC family, plays a critical role in immune response and inflammation. Its primary function is to attract immune cells, particularly T cells and monocytes, to sites of inflammation, thereby facilitating the body's defense mechanisms against pathogens. Research has shown that CCL4L1 is involved in various pathological conditions, including autoimmune diseases, cancer, and infectious diseases, making it an important target for therapeutic interventions. The recombinant production of CCL4L1 protein allows for detailed studies of its biological functions, interactions with receptors, and potential as a biomarker for disease progression. Furthermore, understanding the structure-function relationship of this protein can aid in the design of novel drugs aimed at modulating immune responses. Recent advancements in biotechnology have enabled efficient expression and purification of CCL4L1, paving the way for extensive research on its role in human health and disease. The exploration of CCL4L1 not only enhances our understanding of immune mechanisms but also opens new avenues for targeted therapies in immunological disorders and cancer treatment.
